Differentiation by ascorbic acid of dopamine agonist and antagonist binding sites in striatum
- 1 June 1980
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 26 (22) , 1837-1841
- https://doi.org/10.1016/0024-3205(80)90611-6
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol bindingEuropean Journal of Pharmacology, 1979
- Dopamine receptor binding for agonists and antagonists in thermal exposed membranesEuropean Journal of Pharmacology, 1979
- Guanine nucleotides distinguish between two dopamine receptorsNature, 1979
- Multiple receptors for dopamineNature, 1979
- Antiparkinsonian drug doses and neuroleptic receptorsCellular and Molecular Life Sciences, 1978
- Effect of guanine nucleotides on striatal dopamine receptorsNature, 1978
- Dopamine receptor binding of 3H-ADTN (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene) regulated by guanyl nucleotidesEuropean Journal of Pharmacology, 1978
- Inhibition of dopamine sensitive adenylate cyclase from rat brain striatal homogenates by ascorbic acid1Journal of Neurochemistry, 1977
- Dopamine receptors in human and calf brains, using [3H]apomorphine and an antipsychotic drug.Proceedings of the National Academy of Sciences, 1976
- PROPERTIES OF [HALOPERIDOL-H-3] AND [DOPAMINE-H-3] BINDING ASSOCIATED WITH DOPAMINE RECEPTORS IN CALF BRAIN MEMBRANES1976